Skip to Content

M 473 (Divalproex Sodium Extended-Release 500 mg)

Pill with imprint M 473 is White, Elliptical / Oval and has been identified as Divalproex Sodium Extended-Release 500 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 473

Divalproex sodium extended-release 500 mg M 473
Divalproex sodium extended-release 500 mg M 473
Divalproex sodium extended-release 500 mg M 473
Divalproex sodium extended-release 500 mg M 473

Divalproex Sodium Extended-Release

Imprint
M 473
Strength
500 mg
Color
White
Size
21.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
ammonia, silicon dioxide, dibutyl sebacate, oleic acid, polydextrose, microcrystalline cellulose, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0473 Mylan Pharmaceuticals Inc.
51079-0767 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.